MedPath

Postoperative analgesia for paediatric patients

Phase 4
Completed
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/03/082863
Lead Sponsor
Dr Sunil Chiruvella
Brief Summary

After a through preoperative evaluation, with children who comes under inclusion criteria will be premedicated. standard monitoring will be connected & monitored continuously throughout the surgery. after vascular access, patient administrated general anesthesia. post intubation, inhalational agent will be adjusted to maintain hemodynamic stability within 20% of baseline values, without other opioids or analgesia. following anaesthesia patients will be positioned & prepared for a caudal epidural block using ultrasound guided technique in group A patients, anatomical land mark technique in group B patients with local anesthetic administrated according to the armitage formula ( o.5ml/kg of 0.25% bupivacaine + dexmedetomidine 1mcg/kg). outcome variables will be measured for 24hours postoperatively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Children weighing less than 20 Kgs Children belonging to ASA I and II categories.

Exclusion Criteria

Children with suspected coagulopathy Children with infection at the site of caudal block Children with history of developmental delay and neurological diseases Children with skeletal deformities in the caudal region.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesiaBaseline, 2, 4, 6, 8, 12, 16,20, 24hours
Secondary Outcome Measures
NameTimeMethod
Total duration of analgesiaNumber of punctures & time taken to perform to each block

Trial Locations

Locations (1)

Government general hospital

🇮🇳

Cuddapah, ANDHRA PRADESH, India

Government general hospital
🇮🇳Cuddapah, ANDHRA PRADESH, India
Dr Sunkesula Sonia Begum
Principal investigator
08897573489
sonia.sunkesula@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.